Serum proteomic biomarker discovery reflective of stage and obesity in breast cancer patients.
about
Methyl-binding domain protein-based DNA isolation from human blood serum combines DNA analyses and serum-autoantibody testing.Identification and confirmation of biomarkers using an integrated platform for quantitative analysis of glycoproteins and their glycosylationsMass spectrometry-based serum peptidome profiling accurately and reliably predicts outcomes of pemetrexed plus platinum chemotherapy in patients with advanced lung adenocarcinoma.Identification of a high molecular weight kininogen fragment as a marker for early gastric cancer by serum proteome analysis.Identification of potential serum proteomic biomarkers for clear cell renal cell carcinoma.Magnetic bead-based salivary peptidome profiling for periodontal-orthodontic treatment.Body mass index and serum proteomic profile in breast cancer and healthy women: a prospective study.Biomarkers in the age of omics: time for a systems biology approachDiagnostic model of saliva peptide finger print analysis of primary Sjögren's syndrome patients by using weak cation exchange magnetic beadsA serum protein profile predictive of the resistance to neoadjuvant chemotherapy in advanced breast cancers.Identification of peptide regions of SERPINA1 and ENOSF1 and their protein expression as potential serum biomarkers for gastric cancer.Serum amyloid A: A new potential serum marker correlated with the stage of breast cancer.Increased peri-ductal collagen micro-organization may contribute to raised mammographic density.Label-Free Proteome Analysis of Plasma from Patients with Breast Cancer: Stage-Specific Protein Expression.Advancements in the use of blood tests for cancer screening in women at high risk for endometrial and breast cancer.Proteomic Profiling of Serial Prediagnostic Serum Samples for Early Detection of Colon Cancer in the U.S. Military.Evaluation of histidine-rich glycoprotein tissue RNA and serum protein as novel markers for breast cancer.
P2860
Q31030113-829DC591-3981-4FE4-B4C6-168DB3E753CBQ33728371-A198F7AD-96D8-47E3-A1BD-DB65E49270D2Q33778668-8F39DDC3-EC59-4547-8824-495181DF4A75Q33813676-FD234318-570E-465D-94DA-E3054295C22FQ34450277-E0AA85C0-AA4D-4A92-A100-5AD3B0B9F4BBQ34466902-FBAF3371-F5BF-41CE-9884-4D2848A1E418Q34505013-F51E7277-0E0D-4492-865D-7052B3068CF7Q34692190-853B8BCD-72D1-4FC0-8371-A0D930B46647Q34727360-DB0B1539-8C84-4F65-91A4-E6403407D738Q35497722-E030B9EA-17A1-4DA4-992F-2CEE82F4664AQ35560299-5FD0B8DB-1F7A-4647-B7BD-A89D7378F6AFQ35995489-F0714179-77EB-47C0-B66A-54AEF4AA59ABQ36446246-4FA1FB6D-5535-4DEA-9E3F-0B069A78AAB0Q37620591-468F7180-6D21-40DB-8BAF-57AD8FC08007Q37960202-8BCD67BF-F464-48F6-9ED1-3362BD5E5AE2Q39076980-2EECD886-7AD4-4975-98E4-D2A7E3D8D318Q42454752-B448565E-6B4E-4098-BF06-F40105956F12
P2860
Serum proteomic biomarker discovery reflective of stage and obesity in breast cancer patients.
description
2009 nî lūn-bûn
@nan
2009 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մարտին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Serum proteomic biomarker disc ...... ity in breast cancer patients.
@ast
Serum proteomic biomarker disc ...... ity in breast cancer patients.
@en
type
label
Serum proteomic biomarker disc ...... ity in breast cancer patients.
@ast
Serum proteomic biomarker disc ...... ity in breast cancer patients.
@en
prefLabel
Serum proteomic biomarker disc ...... ity in breast cancer patients.
@ast
Serum proteomic biomarker disc ...... ity in breast cancer patients.
@en
P2093
P1476
Serum proteomic biomarker disc ...... sity in breast cancer patients
@en
P2093
Eric C Feliberti
Izabela D Karbassi
Julius O Nyalwidhe
Kimberly J Jones
Nicholas P Schaub
O John Semmes
Richard R Drake
Roger R Perry
P304
970-8; discussion 978-80
P356
10.1016/J.JAMCOLLSURG.2008.12.024
P577
2009-03-26T00:00:00Z